Mumbai / Abu Dhabi: The Abu Dhabi Investment Authority (ADIA) has announced a significant investment of USD 200 million in Meril, a fast-growing Indian medical technology company, through its wholly owned subsidiary.
The transaction, which will give ADIA an approximate 3% stake in Meril, values the company at an enterprise value of USD 6.6 billion and awaits regulatory clearance from the Competition Commission of India (CCI).
Also Read: STPI MedTech CoE Facilitates INR 70 Lakh Funding Opportunity for Startups
Founded by the Bilakhia Group, Meril is a global MedTech powerhouse headquartered in Vapi, India, with cutting-edge innovation across cardiovascular, structural heart, orthopaedics, endo-surgery, diagnostics, and surgical robotics.
This investment further strengthens the company’s capital base and global position, as it now counts ADIA and Warburg Pincus among its strategic backers.
“This investment by ADIA reinforces confidence in the company’s long-term vision and global ambitions,” said Sanjeev Bhatt, Senior Vice President – Strategy, Meril. “It will help us accelerate growth, attract world-class talent, and enhance our R&D and clinical capabilities.”
Meril operates a 100-acre green MedTech campus, fully powered by renewable energy. With over 13,000 employees, 35+ global subsidiaries, and a presence in 150+ countries, the company is redefining the medical devices landscape through scalable, sustainable, and accessible healthcare innovations.
Also Read: Campus Tank: Chandigarh University Launches Startup Launchpad for Young Innovators
Meril: R&D Ecosystem
The company’s robust R&D ecosystem, comprising 200+ proprietary platforms, supports breakthrough innovations like:
- Myval Transcatheter Heart Valve (THV) series
- MyClip Transcatheter Edge-to-Edge Repair (TEER) system
- MISSO Surgical Robotic System
The company also runs 12 global training academies, equipping 10,000+ healthcare professionals annually, showcasing its commitment to clinical education and outcomes.
The fresh capital infusion will be directed toward expanding the company’s research & development, clinical trials, and global growth initiatives.
With increasing emphasis on localization and sustainability in MedTech, Meril‘s innovation-led approach and clean energy operations place it among the global elite in next-gen healthcare technology.
